The divestment of a significant portion of DuPont's Delrin business could potentially free up capital for the company, which could be used for other strategic investments or to improve its balance sheet. However, the impact on the company's stock price in the short term is uncertain as it would depend on how the market perceives this move and the potential benefits it could bring to the company.